United States Patent and Trademark Office, Patent Assignment 64487/149:
Assignment Of Assignors Interest

Tags No tags have been applied so far. Sign in to add some.
Assignors
Assignee

Lee, Sang Don
Paperwork Executed March 27, 2023

Kim, Jeong A
Paperwork Executed March 31, 2023

Lee, Sang Hyun
Paperwork Executed March 31, 2023

Lee, Jong-soo
Paperwork Executed March 31, 2023

Transfer

Recorded
August 3, 2023

No Logo

Hanmi Pharm Company, Ltd.
Officially Listed As "Hanmi Pharm. Company, Ltd."

Hanmi Pharm Company, Ltd.
550, Dongtangiheung-ro, Hwaseong-si
Gyeonggi-do
SOUTH KOREA

Patents
Correspondent

Therapeutic Use Of Long-acting Conjugate Of Triple Agonist Acting On All Of Glucagon, Glp-1 And Gip Receptors Against Multiple Sclerosis

USX0Patent Application No. 18028348, Filed March 24, 2023

USA1Application Publication No. 20230372448, Issued November 23, 2023

Sughrue Mion, PLLC
2000 Pennsylvania Ave Nw Ste 900
Washington, DC 200061812

Updated November 23, 2023

View this assignment via USPTO Assignments on the Web

Statistics

This assignment has been viewed 0 times.

Issues Laws Cases News Firms Entities Pro